Archive
2020 78 79 80 81 82  
2019 72 73 74 75 76 77
2018 66 67 68 69 70 71
2017 60 61 62 63 64 65
2016 54 55 56 57 58 59
2015 48 49 50 51 52 53
2014 42 43 44 45 46 47
2013 36 37 38 39 40 41
2012 30 31 32 33 34 35
2011 26 27 28 29    
News
Submit your article
Newsletter


Issue № 80. June 2020

State Procurement Structure of Medicines with Unproved Efficiency

Danila A. Uvarov

Postgraduate student, Faculty of Economics, Department of Economics of Innovation, Lomonosov Moscow State University, Moscow, Russian Federation. 
E-mail: bluesvera@gmail.com

Russian healthcare system involves providing citizens with effective and safe medicines that have passed all phases of preclinical and clinical studies. However, State Register of Medicines contains drugs, whose efficacy and safety were not approved by well-designed clinical trials. For example, among such medicines there are homeopathic drugs, which efficacy cannot be established. Also, many of these medicines are being advertised by mass media. Pharmaceutical market divides into two segments — private and government. In private segment drugs are bought by patients, in government segment medicines are provided by national budget. This article analyzes government procurements for medicines that do not comply with the principles of evidence-based medicine. Literature overview showed a lack of publications on this problem. The research basis was the list of mistrusted drugs, which was made by a doctor and which is accepted by the society for evidence based medicine. As a result, drugs were identified and ranked by the number of procured medicines, also geographical and time distributions were made. Then the biggest pharmacotherapeutic groups were described in terms of amount of procurement of the medicines without clinical evidence. The percent of such medicines that are included in the List of Vital and Essential Drugs was evaluated as well as seasonality of procurement. The research is aimed to help to draw attention to the problem of availability of ineffective or unsafe drugs on the Russian market, moreover it is designed to increase efficiency of state procurement management.

Keywords

State procurement, the List of Vital and Essential Drugs, homeopathy, evidence-based medicine, efficacy, drug supply, drug market.

DOI: 10.24411/2070-1381-2019-10065

Comments:
No material published in this journal may be reproduced in print or in electronic form without a link to "E-journal. Public Administrarion".
119991, Room A-710, Shuvalovskiy building, Lomonosov Moscow State University
(27/4, Lomonosovskiy Avenue); phone: +7 (495) 930-85-71
Copyright © 2015 SPA MSU


Яндекс.Метрика